Immix Biopharma, Inc. IMMX Payments to Acquire Short-Term Investments
Payments to Acquire Short-Term Investments at other companies
Other financials
Where this comes from
Reported directly by Immix Biopharma, Inc. in its filing.
Tagged under the XBRL concept us-gaap:PaymentsToAcquireShortTermInvestments.
The official record: Immix Biopharma, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Immix Biopharma, Inc.'s payments to acquire short-term investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Immix Biopharma, Inc.'s payments to acquire short-term investments?
- Immix Biopharma, Inc. (IMMX) reported payments to acquire short-term investments of $7.77M in Q1 2026.
- How has Immix Biopharma, Inc.'s payments to acquire short-term investments changed year-over-year?
- Immix Biopharma, Inc.'s payments to acquire short-term investments increased by 379.5% year-over-year, from $1.62M to $7.77M.